Here we confirm and extend our previous studies demonstrating that the mutagenic potency of 1,2-dibromoethane (DBE) and dibromomethane (DBM) is markedly enhanced (not prevented) in bacteria expressing the O 6 -alkylguanine-DNA alkyltransferase (ATase) encoded by the Escherichia coli ogt gene. We demonstrate that, in close parallel with mutagenesis, the Ogt ATase sensitizes the bacteria to the lethal effects of these carcinogens, suggesting that one or more of the potentially mutagenic lesions induced by DBE and DBM in the presence of Ogt has additional lethal capacity. We further demonstrate that the sensitization to both lethality and mutagenesis by DBE and DBM is a property shared by other DNA alkyltransferases. This objective was accomplished by quantifying the induction of mutations and lethal events in ogt Ϫ ada Ϫ E.coli expressing an exogenous bacterial or mammalian ATase from a multicopy plasmid. Mammalian recombinant ATases enhanced the lethal and mutagenic actions of DBE and suppressed the lack of sensitivity of the vector-transformed bacteria to DBM. In most cases the order of effectiveness of the ATases ranked: murine > human > Ogt > rat. Further comparisons included the full-length Ada ATase from E.coli and a truncated Ada version (T-ada) that retains the O 6 -methylguanine binding domain of the protein. The fulllength Ada ATase was effective in enhancing the lethality but not the mutagenicity induced by DBE and DBM. The T-ada ATase provided less sensitization than Ada to lethality by DBE, but of the three bacterial ATases T-ada yielded the highest sensitization to mutagenesis by this compound. T-ada and Ada ATases were in general less effective than the mammalian versions, with the exception of the rat recombinant ATase. The effectiveness of the different mammalian and bacterial ATases in promoting the deleterious actions of dibromoalkanes was compared with the effectiveness of these proteins in suppressing the lethal and mutagenic effects induced by N-nitroso-N-methylurea. The ability to sensitize E.coli to the lethal and mutagenic effects of DBE and DBM seems restricted to DNA alkyltransferase, since overexpression of thioredoxin (Trx) or glutaredoxin (Grx1) in ogt Ϫ ada Ϫ cells showed no effect, in spite of the reported potential of bioactive dihaloethane-derived species to alkylate Trx.
Introduction
Haloalkanes form a large class of industrial carcinogens with poorly understood modes of action. Representative members of the group, such as dichloromethane or 1,2-dibromoethane (DBE*), are known to be mutagenic and carcinogenic in experimental animals and probably carcinogenic to humans (1) . DBE has been studied extensively, because it was until recently widely used as an industrial chemical, soil and grain fumigant and lead scavenger in petrol (2) . The mutagenicity of DBE has been demonstrated in microorganisms, yeast and other fungi, plants, insects, mammals and human cells (reviewed in 1, 3) . Much less is known about the mutagenic and carcinogenic actions of the structurally related dibromomethane (DBM).
In mammalian systems metabolism of DBE has been proposed to occur by two different pathways (3) . One is mediated by the microsomal mixed function oxygenases of liver that produce 2-bromoacetaldehyde and 2-bromoethanol as potential DNA damaging products. The other involves an initial conjugation with glutathione giving rise to a half-sulfur mustard which rearranges to a reactive episulfonium ion as the ultimate metabolite. Both of these metabolic pathways have also been proposed for dihalomethanes in mammals (4) . The oxidative and conjugation routes for DBE occur at a ratio of 4:1 in rats (5) , but the minor pathway is now thought to be of major importance for mutagenesis and carcinogenesis (6) (7) (8) , whereas the oxidation pathway is regarded as the primary route for DBE clearance (9) .
The binding of DBE to DNA in vitro and in vivo has been proposed to be dependent on glutathione conjugation. An S-[2-(N7-guanyl)ethyl]glutathione adduct has been identified as the major DNA lesion (10, 11) , although a minor reaction at the N1 position of adenine has also been reported (12, 13) . These two adducts have been implicated in the induction of substitutions at G:C and A:T base pairs respectively (8, 13) . In Drosophila the major S- [2-(N7-guanyl) ethyl]glutathione adduct has also been involved in the induction of small rearrangements (a deletion or duplication insertion) (8) . The role of other potential mutagenic lesions which have been detected at very low levels, such as O-guanyl adducts, has been considered negligible (13) .
The genotoxic effects of dihalomethanes have also been linked to glutathione conjugation. The major dGuo adduct of S-(1-acetoxymethyl) glutathione, prepared as an analog of the putative reactive intermediate S- (1-halomethyl) glutathione, was characterized as S- [1-(N2-deoxyguanosinyl) methyl]glutathione (14) , so that although the N7 adduct is dominant with the 2-haloethyl compounds, the methyl species seems to prefer the exocyclic amino group.
There is substantial and compelling evidence that the toxic, mutagenic, chromosome damage and carcinogenic effects of chemical agents that alkylate DNA (mostly the simple monofunctional methylating compounds) can be attenuated by the action of O 6 -alkylguanine-DNA alkyltransferases (hereafter referred to as DNA alkyltransferases or ATases). These are DNA repair proteins that remove alkyl groups from chemically alkylated DNA, mainly from the O 6 position of guanine. During the process, the alkyl group becomes covalently bound to a cysteine residue at the active site of the protein and so the reaction is stoichiometric and autoinactivating, further repair requiring de novo synthesis of more ATase (15) . DNA alkyltransferases from different sources have been studied by numerous authors and the nucleotide sequences of all ATase genes or cDNA so far isolated from bacteria, yeast and mammals indicate the presence of a highly conserved pentapeptide (PCHRV, except yeast which is PCHRI) at the active site of the protein (16) . Nevertheless, systematic comparisons of the biochemical characteristics of the different DNA alkyltransferases have only been carried out to a limited extent.
Escherichia coli has two ATases: the constitutively expressed 19 kDa ogt gene product (17) and the inducible 39 kDa ada gene product (18) (19) (20) . The site for repair of O 6 -methylguanine is located in the C-terminal half of the Ada polypeptide. A second active cysteine in the N-terminal half of Ada removes methyl groups from methylphosphotriesters. Once methylated at this position, Ada induces the expression of several genes, including the ada gene itself (20, 21) . The predominant ATase in wild-type non-adapted E.coli is that encoded by the ogt gene (22) . The two E.coli ATases show different DNA substrate specificities (23) . Accordingly, we have demonstrated that lack of Ogt protein greatly sensitizes the bacterial cells to mutagenesis by long chain alkylating compounds; in comparison, the contribution of inactivation of the ada gene is relatively minor (24) (25) (26) . The sensitization by ogt deficiency to the methylating agents requires, however, the absence of ada encoded protein (24) . Mammalian cells contain a single O 6 -methylguanine activity. There is no good evidence that expression of this activity is regulated or that its regulation is analogous to that described in E.coli and other prokaryotes. Thus mammalian ATase appears to be similar to the constitutive product of the E.coli ogt gene in terms of its non-inducibility (27) .
In a recent report (28) we have found an unexpected role for the ATase encoded by the E.coli ogt gene: the mutagenicities of 1,2-dibromoethane and dibromomethane were substantially enhanced (not prevented) in bacteria expressing the Ogt protein. This represents the first evidence that a DNA repair protein can increase the mutagenicity of environmental chemical carcinogens, thus requiring an urgent and extensive examination in both bacterial and mammalian systems. Here we compare the ability of ATases from different sources to influence the mutagenic and lethal potential of DBE and DBM in E.coli. This objective has been accomplished by quantifying the induction of mutations and lethal events in ogt Ϫ ada Ϫ double mutants transformed with an exogenous bacterial ATase gene or mammalian cDNA.
Materials and methods

Bacterial strains and plasmids
The bacterial strain used in this work is E.coli K12. The vector plasmids, those carrying the gene encoding the Ogt (p261PB) or Ada (pSV2ada) ATase or the Trx (pBHK8) or Grx1 (pBR322ECG) protein and those bearing a truncated ada gene (pTada) or the human (pUC8.0hAT), rat (pUC8.1rAT) or murine (pUC8.0mAT) ATase cDNA have been previously described (16, 26, (29) (30) (31) (32) (33) (34) (35) (36) . All plasmids are in the UC978 strain [araD81, arg56, nad113, ∆(uvrBbio) ogt1::Kan r ada10::Tn10] (26), except pBHK8, pBR322ECG and the corresponding cloning vector, which were in UC5710 [araD81, arg56, nad113, ∆(uvrB-bio) ∆(ogt-fnr)1] (37). Media were according to Davis et al. (38) . Mutagens 1,2-Dibromoethane, dibromomethane and N-nitroso-N-methylurea were purchased from Sigma (St Louis, MO). Mutagens were dissolved in dimethyl sulfoxide, from Merck (Darmstadt, Germany).
Mutagenesis and survival assays
Mutagenesis was assayed by selecting forward mutations to L-arabinose resistance (Ara r ) in a medium containing L-arabinose and a carbon source (glycerol), which is unable to repress araDAB operon expression (39, 40) . The mutagenesis protocol was carried out basically as previously described (40) . Briefly, bacteria were grown at 37°C for 12 h with shaking (90 r.p.m.) in LuriaϪBertani (LB) nutrient medium in the presence of ampicillin (100 µg/ ml). Cells were then harvested by centrifugation and resuspended in VB salts. An aliquot of bacterial suspension (containing~10 8 cells) and the mutagen to be tested were preincubated at 37°C for 20 min with shaking (90 r.p.m.) in 1 ml VB salts. Aliquots of 0.1 ml (~10 7 bacteria) were then combined in 2 ml molten top agar containing a trace amount of 0.5 mg D-glucose for full expression of Ara r mutants (39) and the contents poured onto selective plates. Preincubations with the mutagen solvent were included for spontaneous counts. Selective plates for Ara r mutants were as follows: VB salts containing 17 g/l Difco agar, 2 g/l L-arabinose, 2 g/l glycerol, 40 µg/l arginine, 5 µg/ml D-biotin, 5 µg/ml thiamine, 5 µg/ml nicotinic acid and 100 µg/ml adenine. Bacterial colonies were counted automatically (model 40-10; Analytical Measuring System Ltd, UK). All data represent averages from at least two duplicate plates. Each mutagenesis assay was repeated on at least two separate occasions using a wide range of mutagen concentrations. The numbers of mutants induced by the different doses of mutagen were calculated as m x Ϫ (m 0 ϫs x ), where m x is the number of mutants at dose x, m 0 the number of mutants at dose 0 (spontaneous) and s x the survival fraction at dose x. The slope of the linear regression line fitted to the increasing portion of the corresponding doseϪresponse relationship gave the number of mutants induced per dose of compound (mutants/nmol). For survival determinations 10 5 bacteria were exposed, under the above described conditions, to each dose of mutagen. Aliquots of 0.1 ml (~10 4 bacteria) were then combined in 2 ml molten top agar and plated in LB nutrient agar. The lethal potency of the mutagens was expressed as the dose giving 50% survival (LD 50 ).
Results
The ability of DNA alkyltransferases from different sources to influence the deleterious potential of dibromoalkanes was investigated by quantifying the mutagenic and lethal effects of DBE and DBM in ogt Ϫ ada Ϫ E.coli (UC978 strain) expressing an exogenous bacterial or mammalian ATase from a multicopy plasmid. Bacteria were additionally uvrB defective, because differences in sensitivity to mutagenesis by DBE and DBM between Ogt-proficient and Ogt-deficient bacteria require a uvr Ϫ genetic background (28) , in agreement with the proposed ability of the nucleotide excision repair system to deal with mutagenic lesions induced by dihaloalkanes (41, 42) .
As previously reported (28), UC978 bacteria harboring the ogt ϩ plasmid p261PB showed a markedly increased susceptibility to mutagenesis by DBE as compared with the same cells transformed with the corresponding cloning vector ( Figure 1) ; more notable, the lack of a mutagenic response of these bacteria to DBM was suppressed by overexpressing the Ogt ATase from plasmid p261PB (Figure 2 ). In addition, here we demonstrate that Ogt expression sensitizes the bacteria to the lethal effects of DBE and DBM (Figures 1 and 2) , in close parallel with mutagenesis. Figures 1 and 2 compare the ability of the bacterial Ogt ATase to sensitize E.coli against the deleterious effects of dibromoalkanes with that of the human, rat or murine ATase. The three mammalian recombinant ATases enhanced the lethal and mutagenic actions of DBE and suppressed the lack of sensitivity of the vector-transformed bacteria to DBM. The effectiveness of these ATases in enhancing the mutagenic effects of dibromoalkanes decreased in the sequence mAT Ͼ hAT Ͼ Ogt Ͼ rAT. This order was maintained in protection against killing by DBE (Figure 1 ) but not in protection against killing by DBM (Figure 2) , where mAT Ͼ Ogt Ͼ hAT Ͼ rAT.
Further comparisons (Figures 3 and 4) included the Ada ATase and a truncated version of Ada (T-ada). The T-ada ATase retains the O 6 -methylguanine binding domain (but not the methylphosphotriester ATase segment) (43) . A comparison between the full-length E.coli 39 kDa Ada protein and the truncated version is mandatory since important differences have recently been observed in the in vitro repair of the O 6 -ethylguanine substrate by the 39 kDa Ada protein as compared with the catalytic C-terminus alone (44) . The full-length Ada ATase was able to sensitize E.coli to the lethal actions of both DBE and DBM (Figure 4 ). In contrast, Ada had no influence on the bacterial susceptibility to mutagenesis by these two dibromoalkanes (Figure 3 ). The T-ada ATase provided less sensitization than Ada to lethality by DBE (Figure 4) , but of the three bacterial ATases, T-ada yielded the highest sensitization to mutagenesis by this compound (Figure 3 ). Both Ada and T-ada showed less efficiency in promoting lethality by DBM than by DBE, however, the opposite was observed with Ogt, suggesting differences in the effects induced by the two agents. T-ada and Ada ATases were in general less effective than the mammalian versions, with the exception of the rat recombinant ATase.
The monofunctional methylating agent MNU was assayed for comparison with DBE and DBM. Expression of a mammalian or bacterial ATase diminished the enhanced susceptibility of ogt Ϫ ada Ϫ E.coli to the mutagenic ( Figure 3 ) and lethal effects (Figure 4 ) of MNU. These results were expected, in agreement with the role attributed to O 6 -methylguanine adducts in mutagenesis and lethality, via the mismatch repair system, induced by this agent (27, (45) (46) (47) . Bacterial ATases showed higher effectiveness than mammalian ATases in protection against mutagenesis by MNU; the exception was the murine ATase, which exhibited similar efficiency to those of the bacterial versions. This difference was not so clearly observed in protection against killing by MNU, where all ATases tested showed much similar effectiveness.
Extensive alkylation of cellular proteins as a result of dihaloalkane exposure is known to occur (48) . Thioredoxin (Trx) and glutaredoxin (Grx) are multifunctional ubiquitous proteins that have been isolated as hydrogen donors for ribonucleotide reductase, which is essential for DNA synthesis (49) . Both Trx and Grx contain two redox-active cysteine residues in their active site. Meyer et al. (50) selected E.coli Trx as a model of how protein thiols can be modified by dihaloalkanes. Trx was alkylated upon treatment with the synthetic conjugate S-(2-chloroethyl)glutathione at physiological pH; alkylation occurred primarily at one (Cys32) of the two redox-active cysteine residues of the protein (50). Here we examine if Trx and Grx are able to enhance the lethal and mutagenic effects of DBE and DBM, as observed for the DNA alkyltransferases. To this end, E.coli cells overproducing either Trx or Grx1 from a multicopy plasmid were assayed in parallel with those overproducing the Ogt ATase (Table I ). In marked contrast to the Ogt ATase, Trx and Grx1 did not show any capacity to mediate bacterial sensitization to the deleterious actions of dibromoalkanes.
Discussion
The results reported here confirm and extend our previous studies demonstrating that the mutagenic potency of two dibromoalkanes, DBE and DBM, is markedly enhanced in bacteria by the presence of the DNA alkyltransferase encoded by the E.coli ogt gene (28) . We demonstrated first that the Ogt ATase also sensitizes the bacteria to the lethal effects of these carcinogens, suggesting that one or more of the potentially mutagenic lesions induced by DBE and DBM in the presence of Ogt has additional lethal capacity. We demonstrated further that the sensitization to both lethality and mutagenesis by DBE and DBM is a property shared by other DNA alkyltransferases. In this study recombinant ATase from a murine or human source expressed in ogt Ϫ ada Ϫ defective bacteria showed, in general, much higher efficiency than Ogt in enhancing mutagenesis and lethality by dibromoalkanes. In contrast, rat recombinant ATase was clearly less effective. These differences do not seem attributable to differences in the expression levels of these proteins in the harboring bacterial strains (26) , since, in contrast to DBE and DBM, the rat ATase was as protective as the human ATase against the mutations and lethal events induced by MNU. Similarly, while murine ATase was 160-fold more effective than bacterial Ogt ATase in enhancing mutation induction by DBM, these two proteins suppressed MNU mutagenesis with identical efficiency.
We have previously reported (28) that of the two E.coli ATases, the ogt-encoded protein is the principal determinant in promoting dibromoalkane mutagenicity in E.coli. Thus only when the ogt gene was inactivated was resistance to mutagenesis greatly increased; the contribution of inactivation of the ada gene was relatively minor. Furthermore, induction of the adaptive response provided essentially no sensitivity to dibromoalkane mutagenesis in either an ogt ϩ or ogt Ϫ background. In agreement with these previous results, here we have demonstrated that overexpression of the full-length ada gene did not sensitize ogt Ϫ ada Ϫ defective bacteria to mutation induction by DBE and DBM. In contrast, overexpression of the truncated ada gene (T-ada) was effective, to even a greater extent than the ogt gene with respect to DBE mutagenesis. Sensitization to the lethal effects of dibromoalkanes did not follow exactly the same pattern as mutation induction, since introduction into ogt Ϫ ada Ϫ E.coli of plasmids containing the entire ada gene provided greater response than plasmids containing the truncated ada version. This might indicate differences between the mechanisms of sensitization to lethality and mutagenesis.
Alkylated protein is considered the major macromolecular product of dihaloalkane exposure (48) . Nevertheless, the ability to sensitize bacterial cells to both the lethal and mutagenic effects of dibromoalkanes seems a property not shared by proteins other than the DNA alkyltransferases. Accordingly, Trx and Grx showed no effect, in spite of the reported potential of the bioactive dihaloethane-derived species to alkylate Trx (50) .
The finding that expression in E.coli of mammalian ATases, including that from a human source, causes a remarkable increase in mutational and lethal events upon exposure to both DBE and DBM, suggests the possible relevance of this mechanism in causing genotoxic damage in mammals. This is supported by recent observations (N.Abril and G.P.Margison, personal communication) showing that human ATase-defective cells transfected with an expression vector containing the human cDNA are more sensitive than control cells to both the toxic and mutagenic effects of DBE. Proof of this proposal remains to be established in vivo. Such in vivo animal studies are of great interest in the light of the varied and extensive uses of dihaloalkanes and the proposal that recombinant ATases might be used in gene therapy strategies directed at the protection of bone marrow cells from the cytotoxic side effects of alkylation-based chemotherapeutic regimens. The possibility that the extent of in vivo sensitization to the deleterious actions of dihaloalkanes could range considerably among different ATases should be taken into account when looking for optimized gene therapy schemes involving mutant human proteins with increased ATase activity (51) .
A number of experiments are at present in progress in order to establish the mechanism(s) by which ATases from different sources could sensitize cells to the lethal and mutagenic effects of dibromoalkanes. Our current working hypothesis is that the ATase could form a covalent complex with the compound through direct reaction with the active site cysteine residue. It might be that such a reaction would activate the dibromoalkane, mediating its binding to DNA, as postulated for the glutathionedependent activation pathway. This hypothesis agrees with: (i) recent unpublished data (N.Abril and G.P. Margison, personal communication) showing that the O 6 -methylguanine DNAmethyltransferase activity of ATases purified from different sources is inactivated in vitro by pretreatment with DBE in the absence of glutathione; (ii) the observation that the mutagenicity induced by DBE is totally dependent on glutathione only in the absence of Ogt (ogt Ϫ strain) (28) . Accordingly, in E.coli Ogt-proficient cells glutathione-mediated plus Ogt-mediated mutagenicity can be observed (28) . This second route seems much more important for DBM than for DBE (28, this paper) ; the smaller size of DBM could facilitate its reaction with the active site cysteine of the DNA alkyltransferase.
